A recent study from Ontario, Canada, has revealed that Bavarian Nordic A/S’s smallpox vaccine, marketed as Imvamune in Canada and Jynneos in the US, was 58% effective in preventing mpox infections after a single dose.
Trending
- CBN survey: Low-income Nigerians bear brunt of inflation
- Lagos moves beyond dumpsites
- LASCOPA, NDLEA partner on drug abuse
- RDI urges action to save Okun Alfa
- Doctor urges Nigerians to prevent illness
- Kaduna begins diphtheria vaccination
- Who is policing the poison in Nigeria’s food chain?
- Dutse residents seek street lights
